Cybeats Reports on Approval of the U.S. Omnibus Appropriations Bill That Mandates SBOM for Medical Devices
Summary
Cybeats recently announced commercial pilots1 with Fortune 500 companies which include medical device manufacturers, who are proactively seeking SBOM management solutions in preparation for FDA regulations. We expect our market-ready product to see accelerating traction in the medical device marketplace where requirements to implement SBOM are not optional." Additionally, new SBOM requirements will force vendors to determine if problems exist in the third-party components they leverage in their software. Our platform provides customers with deep visibility and universal transparency into their software supply chain, as a result enables them to increase operational efficiencies and revenue. The Company undertakes no obligation to update forward-looking information if circumstances or managements estimates or opinions should change except as required by law.
Classifications
AskAI Classifications
LabelsLinked Companies
